These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 8491848)

  • 21. Neuropsychological, psychiatric, and cerebral blood flow findings in vascular dementia and Alzheimer's disease.
    Starkstein SE; Sabe L; Vazquez S; Teson A; Petracca G; Chemerinski E; Di Lorenzo G; Leiguarda R
    Stroke; 1996 Mar; 27(3):408-14. PubMed ID: 8610304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apathy and loss of insight in Alzheimer's disease: a SPECT imaging study.
    Ott BR; Noto RB; Fogel BS
    J Neuropsychiatry Clin Neurosci; 1996; 8(1):41-6. PubMed ID: 8845700
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cognitive correlates of regional cerebral blood flow in Alzheimer's disease.
    Eberling JL; Reed BR; Baker MG; Jagust WJ
    Arch Neurol; 1993 Jul; 50(7):761-6. PubMed ID: 8323482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors of perceived memory impairment: do they differ in Alzheimer's disease versus normal aging?
    Brustrom JE; Ober BA
    J Clin Exp Neuropsychol; 1998 Jun; 20(3):402-12. PubMed ID: 9845166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relation of anosognosia to frontal lobe dysfunction in Alzheimer's disease.
    Michon A; Deweer B; Pillon B; Agid Y; Dubois B
    J Neurol Neurosurg Psychiatry; 1994 Jul; 57(7):805-9. PubMed ID: 8021665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heterogeneity of Cognitive Anosognosia and its Variation with the Severity of Dementia in Patients with Alzheimer's Disease.
    Avondino E; Antoine P
    J Alzheimers Dis; 2016; 50(1):89-99. PubMed ID: 26638866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cognitive function and regional cerebral blood flow in Parkinson's disease.
    Jagust WJ; Reed BR; Martin EM; Eberling JL; Nelson-Abbott RA
    Brain; 1992 Apr; 115 ( Pt 2)():521-37. PubMed ID: 1606480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alzheimer's disease and depression: neuropsychological impairment and progression of the illness.
    Lopez OL; Boller F; Becker JT; Miller M; Reynolds CF
    Am J Psychiatry; 1990 Jul; 147(7):855-60. PubMed ID: 2356870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Awareness of cognitive deficits and anosognosia in probable Alzheimer's disease.
    Lopez OL; Becker JT; Somsak D; Dew MA; DeKosky ST
    Eur Neurol; 1994; 34(5):277-82. PubMed ID: 7995303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unawareness of memory impairment and behavioral abnormalities in patients with Alzheimer's disease: relation to professional health care burden.
    Al-Aloucy MJ; Cotteret R; Thomas P; Volteau M; Benmaou I; Dalla Barba G
    J Nutr Health Aging; 2011 May; 15(5):356-60. PubMed ID: 21528161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Denial of memory deficit in Alzheimer's disease.
    Sevush S; Leve N
    Am J Psychiatry; 1993 May; 150(5):748-51. PubMed ID: 8480820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Late life depression or prodromal Alzheimer's disease: Which tools for the differential diagnosis?].
    Gasser AI; Salamin V; Zumbach S
    Encephale; 2018 Feb; 44(1):52-58. PubMed ID: 28434642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cognitive reserve: a SPECT study of 132 Alzheimer's disease patients with an education range of 0-19 years.
    Liao YC; Liu RS; Teng EL; Lee YC; Wang PN; Lin KN; Chung CP; Liu HC
    Dement Geriatr Cogn Disord; 2005; 20(1):8-14. PubMed ID: 15832030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cross domain self-monitoring in anosognosia for memory loss in Alzheimer's disease.
    Chapman S; Colvin LE; Vuorre M; Cocchini G; Metcalfe J; Huey ED; Cosentino S
    Cortex; 2018 Apr; 101():221-233. PubMed ID: 29518705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cognitive deficits in a suicidal depressed Alzheimer's patient: a specific vulnerability?
    Richard-Devantoy S; Annweiler C; Le Gall D; Beauchet O
    Int J Geriatr Psychiatry; 2014 Mar; 29(3):326-8. PubMed ID: 24515447
    [No Abstract]   [Full Text] [Related]  

  • 36. Examination of the metacognitive errors that contribute to anosognosia in Alzheimer's disease.
    Cosentino S; Zhu C; Bertrand E; Metcalfe J; Janicki S; Cines S
    Cortex; 2016 Nov; 84():101-110. PubMed ID: 27750070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alzheimer's disease camouflaged by histrionic personality disorder.
    Hellwig S; Dykierek P; Hellwig B; Zwernemann S; Meyer PT
    Neurocase; 2012 Feb; 18(1):75-9. PubMed ID: 21942937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Positive affect and regional cerebral blood flow in Alzheimer's disease.
    Hayashi S; Terada S; Sato S; Oshima E; Miki T; Yokota O; Ishihara T; Yamada N
    Psychiatry Res Neuroimaging; 2016 Oct; 256():15-20. PubMed ID: 27640073
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anosognosia in patients with Alzheimer's disease: current perspectives.
    Tagai K; Nagata T; Shinagawa S; Shigeta M
    Psychogeriatrics; 2020 May; 20(3):345-352. PubMed ID: 31930617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anosognosia in Alzheimer's disease: a study of associated factors.
    Migliorelli R; Tesón A; Sabe L; Petracca G; Petracchi M; Leiguarda R; Starkstein SE
    J Neuropsychiatry Clin Neurosci; 1995; 7(3):338-44. PubMed ID: 7580194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.